Study SBX-01-101: A Stool Collection Study in Colorectal Cancer (CRC) Patients Treated With Irinotecan-Based Regimens
Withdrawn before enrolling
Conditions studied: Colorectal Cancer
In brief
The primary objective of the study is to determine whether there is a correlation between the intestinal side effects of chemotherapy treatment and the expression/activity profiles of glucuronidase enzymes in the stool microbiome of the target patient population.
Key facts
- Study ID
- NCT05821582
- Run by
- Sanguine Biosciences
- People needed
- 0
- Starts
- 2023-03-27
- Expected to finish
- 2023-10-05
- Last updated by the study team
- 2023-10-12
Who can join
Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Sanguine Biosciences, Inc. — Woburn, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.